These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12373087)

  • 1. A rare, in-frame BCR-ABL fusion (e13a3) in a patient with an aggressive chronic myeloid leukaemia.
    Otazú IB; Belén Rivero M; Olício R; Pinto A; Zalcberg I; Seuánez HN
    Acta Haematol; 2002; 108(3):150-3. PubMed ID: 12373087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two patients with novel BCR/ABL fusion transcripts (e8/a2 and e13/a2) resulting from translocation breakpoints within BCR exons.
    How GF; Lim LC; Kulkarni S; Tan LT; Tan P; Cross NC
    Br J Haematol; 1999 May; 105(2):434-6. PubMed ID: 10233416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical course.
    Byrne JL; Carter GI; Davies JM; Haynes AP; Russell NH; Cross NC
    Br J Haematol; 1998 Dec; 103(3):791-4. PubMed ID: 9858233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of BCR-ABL rearrangement in chronic myeloid leukemia.
    Colleoni GW; Costa FF; Grignolli CR; Silva RS; Chauffaille ML; Kerbauy J; Saad ST
    Braz J Med Biol Res; 1996 Oct; 29(10):1307-10. PubMed ID: 9181101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myelogenous leukemia with e13a3 (b2a3) type of BCR-ABL transcript having a DNA breakpoint between ABL exons a2 and a3.
    Liu LG; Tanaka H; Ito K; Kyo T; Ito T; Kimura A
    Am J Hematol; 2003 Dec; 74(4):268-72. PubMed ID: 14635208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two Ph chromosome positive chronic myelogenous leukemia patients with rare bcr/abl fusion gene].
    Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Shi HL; Qiu JY; Lu DP; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):409-12. PubMed ID: 15355693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes].
    Gui X; Pan J; Qiu H; Cen J; Xue Y; Chen S; Shen H; Yao L; Zhang J; Wu Y; Chen Y
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):210-4. PubMed ID: 24666486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atypical BCR-ABL transcripts in patients with chronic myeloid leukemia--the scheme for the diagnosis and monitoring of minimal residual disease].
    Link-Lenczowska D; Sacha T; Zawada M; Czekalska S; Florek I; Skotnicki AB
    Przegl Lek; 2014; 71(5):258-62. PubMed ID: 25248240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myeloid leukemia with an e13a3 BCR-ABL fusion: benign course responsive to imatinib with an RT-PCR advisory.
    Snyder DS; McMahon R; Cohen SR; Slovak ML
    Am J Hematol; 2004 Feb; 75(2):92-5. PubMed ID: 14755375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA.
    Baxter EJ; Hochhaus A; Bolufer P; Reiter A; Fernandez JM; Senent L; Cervera J; Moscardo F; Sanz MA; Cross NC
    Hum Mol Genet; 2002 Jun; 11(12):1391-7. PubMed ID: 12023981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of breakpoints, and relationship to BCR-ABL RNA expression, in Philadelphia-chromosome-positive chronic myeloid leukaemia patients with a breakpoint around exon 14 (b3) of the BCR gene.
    Mills KI; Sproul AM; Leibowitz D; Burnett AK
    Leukemia; 1991 Nov; 5(11):937-41. PubMed ID: 1961034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of BCR/ABL variants in chronic myeloid leukemia patients using multiplex RT-PCR.
    Bennour A; Ouahchi I; Moez M; Elloumi M; Khelif A; Saad A; Sennana H
    Clin Lab; 2012; 58(5-6):433-9. PubMed ID: 22783572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia.
    Barnes DJ; Melo JV
    Acta Haematol; 2002; 108(4):180-202. PubMed ID: 12432215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel type of BCR-ABL transcript in a chronic myelogenous leukaemia patient relapsed after bone marrow transplantation.
    Roman J; Parziale A; Gottardi E; De Micheli D; Cilloni D; Tiribelli M; Gonzalez MG; del Carmen Rodriguez M; Torres A; Saglio G
    Br J Haematol; 2000 Nov; 111(2):644-6. PubMed ID: 11122114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete cytogenetic response to Nilotinib in a chronic myeloid leukemia case with a rare e13a3(b2a3) BCR-ABL fusion transcript: A case report.
    Liu B; Zhang W; Ma H
    Mol Med Rep; 2016 Mar; 13(3):2635-8. PubMed ID: 26847385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are aberrant BCR--ABL transcripts more common than previously thought?
    Wilson GA; Vandenberghe EA; Pollitt RC; Rees DC; Goodeve AC; Peake IR; Reilly JT
    Br J Haematol; 2000 Dec; 111(4):1109-11. PubMed ID: 11167748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of genomic BCR-ABL breakpoints in chronic myeloid leukaemia by PCR.
    Zhang JG; Goldman JM; Cross NC
    Br J Haematol; 1995 May; 90(1):138-46. PubMed ID: 7786776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
    Yaghmaie M; Ghaffari SH; Ghavamzadeh A; Alimoghaddam K; Jahani M; Mousavi SA; Irvani M; Bahar B; Bibordi I
    Arch Iran Med; 2008 May; 11(3):247-51. PubMed ID: 18426313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints.
    Martinelli G; Terragna C; Amabile M; Montefusco V; Testoni N; Ottaviani E; de Vivo A; Mianulli A; Saglio G; Tura S
    Haematologica; 2000 Jan; 85(1):40-6. PubMed ID: 10629590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3
    Massimino M; Stella S; Tirrò E; Consoli ML; Pennisi MS; Puma A; Vitale SR; Romano C; Zammit V; Stagno F; DI Raimondo F; Manzella L
    Anticancer Res; 2019 Jul; 39(7):3949-3954. PubMed ID: 31262926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.